Display options
Cite
Zhu J, Nguyen D, Ouyang H, et al. Inhibition of RhoA/Rho-kinase pathway suppresses the expression of extracellular matrix induced by CTGF or TGF-β in ARPE-19. Int J Ophthalmol. 2013;6(1):8-14doi: 10.3980/j.issn.2222-3959.2013.01.02.
Zhu, J., Nguyen, D., Ouyang, H., Zhang, X. H., Chen, X. M., & Zhang, K. (2013). Inhibition of RhoA/Rho-kinase pathway suppresses the expression of extracellular matrix induced by CTGF or TGF-β in ARPE-19. International journal of ophthalmology, 6(1), 8-14. https://doi.org/10.3980/j.issn.2222-3959.2013.01.02
Zhu, Jing, et al. "Inhibition of RhoA/Rho-kinase pathway suppresses the expression of extracellular matrix induced by CTGF or TGF-β in ARPE-19." International journal of ophthalmology vol. 6,1 (2013): 8-14. doi: https://doi.org/10.3980/j.issn.2222-3959.2013.01.02
Zhu J, Nguyen D, Ouyang H, Zhang XH, Chen XM, Zhang K. Inhibition of RhoA/Rho-kinase pathway suppresses the expression of extracellular matrix induced by CTGF or TGF-β in ARPE-19. Int J Ophthalmol. 2013;6(1):8-14. doi: 10.3980/j.issn.2222-3959.2013.01.02. Epub 2013 Feb 18. PMID: 23550216; PMCID: PMC3580241.
Copy Download .nbib Format: NLM
Share it on

Int J Ophthalmol. 2013;6(1):8-14. doi: 10.3980/j.issn.2222-3959.2013.01.02. Epub 2013 Feb 18.

Inhibition of RhoA/Rho-kinase pathway suppresses the expression of extracellular matrix induced by CTGF or TGF-β in ARPE-19.

International journal of ophthalmology

Jing Zhu, Duy Nguyen, Hong Ouyang, Xiao-Hui Zhang, Xiao-Ming Chen, Kang Zhang

Affiliations

  1. Department of Ophthalmology, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China ; Department of Ophthalmology and Shiley Eye Center, and Institute for Genomic Medicine, University of California San Diego, La Jolla, CA 92093, USA.

PMID: 23550216 PMCID: PMC3580241 DOI: 10.3980/j.issn.2222-3959.2013.01.02

Abstract

AIM: To investigate the role of Rho-associated protein kinase (ROCK) inhibitor, Y27632, in mediating the production of extracellular matrix (ECM) components including fibronectin, matrix metallo-proteinase-2 (MMP-2) and type I collagen as induced by connective tissue growth factor (CTGF) or transforming growth factor-β (TGF-β) in a human retinal pigment epithelial cell line, ARPE-19.

METHODS: The effect of Y27632 on the CTGF or TGF-β induced phenotype in ARPE-19 cells was measured with immunocytochemistry as the change in F-actin. ARPE-19 cells were treated with CTGF (1, 10, 100ng/mL) and TGF-β (10ng/mL) in serum free media, and analyzed for fibronectin, laminin, and MMP-2 and type I collagen by RT-qPCR and immunocytochemistry. Cells were also pretreated with an ROCK inhibitor, Y27632, to analyze the signaling contributing to ECM production.

RESULTS: Treatment of ARPE-19 cells in culture with TGF-β or CTGF induced an ECM change from a cobblestone morphology to a more elongated swirl pattern indicating a mesenchymal phenotype. RT-qPCR analysis and different gene expression analysis demonstrated an upregulation in expression of genes associated with cytoskeletal structure and motility. CTGF or TGF-β significantly increased expression of fibronectin mRNA (P=0.006, P=0.003 respectively), laminin mRNA (P=0.006, P=0.005), MMP-2 mRNA (P= 0.006, P= 0.001), COL1A1 mRNA (P=0.001, P=0.001), COL1A2 mRNA (P=0.001, P=0.001). Preincubation of ARPE-19 with Y27632 (10mmol/L) significantly prevented CTGF or TGF- β induced fibronectin (P=0.005, P=0.003 respectively), MMP-2 (P= 0.003, P=0.002), COL1A1 (P=0.006, P=0.003), and COL1A2 (P=0.006, P=0.004) gene expression, but not laminin (P=0.375, P=0.516).

CONCLUSION: Our study demonstrated that both TGF-β and CTGF upregulate the expression of ECM components including fibronectin, laminin, MMP-2 and type I collagen by activating the RhoA/ROCK signaling pathway. During this process, ARPE-19 cells were shown to change from an epithelial to a mesenchymal phenotype in vitro. Y27632, a ROCK inhibitor, inhibited the transcription of fibronectin, MMP-2 and type I collagen, but not laminin. The data from our work suggest a role for CTGF as a profibrotic mediator. Inhibiting the RhoA/ROCK pathway represents a potential target to prevent the fibrosis of RPE cells. This might lead to a novel therapeutic approach to preventing the onset of early PVR.

Keywords: Connective tissue growth factor; Rho-associated protein kinase inhibitor; proliferative vitreoretinopathy; transforming growth factor-β

References

  1. Invest Ophthalmol Vis Sci. 2009 Apr;50(4):1903-10 - PubMed
  2. Atherosclerosis. 2008 Jan;196(1):136-145 - PubMed
  3. Radiother Oncol. 2005 Aug;76(2):219-25 - PubMed
  4. Pharm Res. 2008 Oct;25(10):2447-61 - PubMed
  5. Cell Growth Differ. 1996 Apr;7(4):469-80 - PubMed
  6. Keio J Med. 2004 Jun;53(2):74-7 - PubMed
  7. J Clin Invest. 1989 May;83(5):1661-6 - PubMed
  8. Invest Ophthalmol Vis Sci. 2008 Sep;49(9):4078-88 - PubMed
  9. Lab Invest. 2004 Oct;84(10):1245-58 - PubMed
  10. Exp Eye Res. 2007 Mar;84(3):464-72 - PubMed
  11. FEBS J. 2006 Aug;273(16):3639-49 - PubMed
  12. Exp Cell Res. 1997 May 25;233(1):63-77 - PubMed
  13. Jpn J Ophthalmol. 2006 May-Jun;50(3):229-34 - PubMed
  14. Ophthalmic Res. 2001 Mar-Apr;33(2):80-6 - PubMed
  15. Invest Ophthalmol Vis Sci. 2002 Nov;43(11):3465-72 - PubMed
  16. Wound Repair Regen. 2007 Nov-Dec;15(6):817-24 - PubMed
  17. J Cell Physiol. 2008 Aug;216(2):520-6 - PubMed
  18. Graefes Arch Clin Exp Ophthalmol. 1988;226(4):357-61 - PubMed
  19. J Invest Dermatol. 1996 Sep;107(3):404-11 - PubMed
  20. Exp Eye Res. 2006 Mar;82(3):362-70 - PubMed
  21. Invest Ophthalmol Vis Sci. 2006 Feb;47(2):729-37 - PubMed
  22. Invest Ophthalmol Vis Sci. 2001 Oct;42(11):2534-41 - PubMed
  23. Ophthalmic Genet. 2009 Jun;30(2):63-8 - PubMed
  24. J Endocrinol. 2003 Aug;178(2):169-75 - PubMed
  25. Ophthalmic Res. 2005 Nov-Dec;37(6):289-92 - PubMed
  26. Nat Neurosci. 2009 Jan;12(1):5-6 - PubMed
  27. Am J Med Genet. 1993 Jan 15;45(2):140-51 - PubMed
  28. Physiol Rev. 2005 Jul;85(3):845-81 - PubMed
  29. Graefes Arch Clin Exp Ophthalmol. 1994 Jan;232(1):40-6 - PubMed
  30. Prog Retin Eye Res. 2007 Sep;26(5):516-54 - PubMed

Publication Types